No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
2023 to 2024 seasonal influenza vaccine effective for reducing risk
Feb 29, 2024
Vaccine effectiveness against influenza-linked outpatient visits ranged from 33 to 49%, and against hospitalization it ranged from 41 to 44% among adults.